Linda Morrow Selected Research

Linda Morrow Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2011
5	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 03/2011
4	Insulin Resistance 01/2022 - 09/2013
4	Body Weight (Weight, Body) 11/2020 - 01/2014
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 03/2011
2	Non-alcoholic Fatty Liver Disease 01/2021 - 09/2013
2	Obesity 11/2020 - 01/2018
2	Weight Loss (Weight Reduction) 11/2020 - 09/2013
2	Overweight 11/2020 - 01/2019
2	Candidiasis (Moniliasis) 01/2014 - 01/2014
1	Schizophrenia (Dementia Praecox) 01/2022
1	Hyperinsulinism (Hyperinsulinemia) 01/2022
1	Weight Gain 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hyperglycemia 01/2018
1	Dyslipidemias (Dyslipidemia) 08/2016
1	Pain (Aches) 07/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2013
1	Diabetes Mellitus 07/2011

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2011
9	Insulin (Novolin)FDA Link 01/2022 - 03/2011
3	CanagliflozinIBA 10/2014 - 01/2014
3	SodiumIBA 10/2014 - 01/2014
3	SymportersIBA 10/2014 - 01/2014
2	InsulinsIBA 01/2022 - 03/2011
2	Metformin (Glucophage)FDA LinkGeneric 10/2014 - 01/2014
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 03/2012 - 03/2011
2	Insulin Lispro (Humalog)FDA Link 03/2012 - 03/2011
1	C-PeptideIBA 01/2022
1	3-carboxamido-4-hydroxynaltrexoneIBA 01/2022
1	Olanzapine (Zyprexa)FDA Link 01/2022
1	efpeglenatideIBA 01/2021
1	Liraglutide FDA Link 01/2021
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	fibroblast growth factor 21IBA 11/2020
1	AdiponectinIBA 11/2020
1	CarbohydratesIBA 11/2020
1	Soluble Guanylyl CyclaseIBA 01/2020
1	praliciguatIBA 01/2020
1	LDL CholesterolIBA 01/2019
1	Proprotein Convertase 9IBA 01/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	MK-2640IBA 01/2019
1	MK-1293IBA 01/2018
1	Insulin Glargine (Lantus)FDA Link 01/2018
1	Prostaglandin D2IBA 01/2018
1	bimagrumabIBA 01/2018
1	AlbuminsIBA 08/2016
1	ApolipoproteinsIBA 08/2016
1	ISIS 304801IBA 08/2016
1	Triglycerides (Triacylglycerol)IBA 08/2016
1	FructosamineIBA 08/2016
1	Apolipoprotein C-IIIIBA 08/2016
1	insulin degludecIBA 04/2014
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2014
1	(1- (3- isopropyl- 1,2,4- oxadiazol- 5- yl)piperidin- 4- yl)methyl methanesulfonateIBA 01/2014
1	Hormones (Hormone)IBA 01/2014
1	LipidsIBA 09/2013
1	EnzymesIBA 09/2013
1	Bile Acids and Salts (Bile Acids)IBA 09/2013
1	Alanine Transaminase (SGPT)IBA 09/2013
1	obeticholic acidIBA 09/2013
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2012

Therapy/Procedure

3	Glycemic Control 01/2022 - 03/2011
2	Therapeutics 11/2020 - 01/2020
2	Injections 07/2015 - 03/2011
1	Ostomy 07/2021
1	Aftercare (After-Treatment) 08/2016
1	Intramuscular Injections 07/2015
1	Subcutaneous Injections 03/2012